Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical lidocaine for focal peripheral neuropathic pain by pain phenotype
2012-003077-26Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine in Peripheral neuropathic pain, postherpetic neuralgia (PHN) and Neuralgia (2 arms), sponsored by University Hospital Odense. Primary endpoint: Primary efficacy: pain intensity. Started Aug 2012; status: completed.
02
Drugs
lidocaine
03
Conditions
Peripheral neuropathic painpostherpetic neuralgia (PHN)Neuralgia
Beyond the preview
Go deeper on 2012-003077-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003077-26.